Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol

Hodson, L; Parry, SA; Cornfield, T; Charlton, C; Low, WS; Green, CJ; Rosqvist, F

Rosqvist, F (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, S-75236 Uppsala, Sweden.

UPSALA JOURNAL OF MEDICAL SCIENCES, 2020; 125 (3): 211

Abstract

Background: Hepatic de novo lipogenesis (DNL) is ideally measured in very low-density lipoprotein (VLDL)-triacylglycerol (TAG). In the fasting state, ......

Full Text Link